Mar 26, 2024 / 08:30PM GMT
Operator
Hello, and welcome to the NovaBay Pharmaceuticals fourth-quarter and full year 2023 financial results conference call. All participants will be in listen-only mode. (Operator Instructions). As a reminder, this conference is being recorded.
I would now like to hand the call to Jody Cain. Please go ahead.
Jody Cain - NovaBay Pharmaceuticals Inc - IR Contact Officer
This is Jody Cain with LHA. Thank you for participating in today's call. Joining me from NovaBay are Justin Hall, Chief Executive Officer and General Counsel, and Tommy Law, Interim Chief Financial Officer.
I'd like to remind listeners that comments made during this call by management will include forward-looking statements within the meaning of federal securities laws. These forward-looking statements involve risks and uncertainties that could cause actual results to be materially different from any anticipated results.
In particular, there is uncertainty about circumstances beyond the company's control that impact the broader economy. This means that results could change
Q4 2023 NovaBay Pharmaceuticals Inc Earnings Call Transcript
Mar 27, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers